Subscribe To
Spero Therapeutics to Present Data at the 33rd European Congress of Clinical Microbiology and Infectious Diseases
CAMBRIDGE, Mass., April 14, 2023 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced two poster presentations at the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) […] The post Spero Therapeutics to Present Data at the...
Read More
Content Topics
Spero
Therapeutics
Present
Data
33rd
European
Congress
Clinical
Microbiology
Infectious
Diseases
Forex
Posted: Apr 14 2023, 12:05
Author Name: forextv
Views: 082060